Steep Hill Inc (STPH) AI Stock Analysis

• Market Cap: C$889.83K
• Dividend Yield: N/A
• Average Volume (3M): 12.40K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.08
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: CA
• Employees: 6
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): >-0.01
• Shares Outstanding: 16,167,885
• 10 Day Avg. Volume: 9,973
• 30 Day Avg. Volume: 12,401
• PEG Ratio: >-0.01
• Price to Book (P/B): 0.12
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -0.64
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 49 Neutral
• Price Target: C$0.06 ▼(-8.33% Downside)
• Action: Reiterated Date: 12/30/25
• Date: Action: Reiterated 12/30/25

The score is held back primarily by weak and unstable operating results and recent cash burn despite a low-debt balance sheet. Technical signals are neutral-to-soft, while valuation looks optically cheap on P/E but is discounted by earnings quality concerns. The reverse takeover and related restructuring/financing are meaningful potential catalysts but introduce significant execution and transition risk.

Positive Factors

Strategic Acquisition

The acquisition of Lir Life Sciences positions Steep Hill in the biopharmaceutical sector, potentially expanding its market reach and product offerings, which could enhance long-term growth prospects.

Negative Factors

Lack of Revenue

The absence of revenue poses a significant risk to Steep Hill's long-term sustainability, as it limits the company's ability to fund operations and growth initiatives.

Steep Hill Inc Business Overview & Revenue Model

Company Description

Steep Hill Inc., a cannabis science and technology company, provides laboratory testing, quality assurance, and data analytics services in Canada and the United States. It offers analytical testing services, such as cannabinoids, terpenes, pestici...

Read more

Steep Hill Inc., a cannabis science and technology company, provides laboratory testing, quality assurance, and data analytics services in Canada and the United States. It offers analytical testing services, such as cannabinoids, terpenes, pestici...

How the Company Makes Money

Steep Hill Inc generates revenue primarily through its laboratory testing services. Key revenue streams include fees charged for cannabis potency testing, which measures the levels of THC and CBD present in products, and safety screening for conta...

Read more

Steep Hill Inc generates revenue primarily through its laboratory testing services. Key revenue streams include fees charged for cannabis potency testing, which measures the levels of THC and CBD present in products, and safety screening for conta...

Steep Hill Inc Financial Statement Overview

Breakdown	TTM	Dec 2024	Mar 2024	Mar 2023	Mar 2022	Dec 2020
Income Statement
Total Revenue	0.00	0.00	0.00	1.18M	938.57K	0.00
Gross Profit	-3.84K	-15.37K	-16.64K	1.18M	938.57K	-118.78K
EBITDA	-197.36K	-188.23K	-444.66K	-3.73M	-3.97M	-1.95M
Net Income	384.74K	337.71K	793.30K	-7.12M	-4.53M	-2.08M
Balance Sheet
Total Assets	2.08M	2.28M	2.76M	3.02M	7.43M	1.70M
Cash, Cash Equivalents and Short-Term Investments	2.03M	2.21M	2.61M	1.91M	2.58M	438.63K
Total Debt	0.00	0.00	18.55K	79.97K	718.20K	442.48K
Total Liabilities	162.30K	258.56K	1.11M	2.17M	1.73M	551.85K
Stockholders Equity	1.91M	2.02M	1.65M	842.34K	5.77M	1.20M
Cash Flow
Free Cash Flow	-206.75K	-381.46K	742.34K	-1.82M	-1.57M	-1.56M
Operating Cash Flow	-206.75K	-381.46K	742.34K	-1.82M	-1.57M	-1.25M
Investing Cash Flow	150.00K	0.00	-2.00M	1.48M	-336.96K	-280.03K
Financing Cash Flow	-3.46K	-19.06K	-53.22K	-253.84K	4.04M	402.02K

Steep Hill Inc Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.06
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:STPH, the sentiment is Positive. The current price of 0.06 is below the 20-day moving average (MA) of 0.06, below the 50-day MA of 0.06, and above the 200-day MA of 0.06, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 49.24 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:STPH.

Steep Hill Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
ATLE	50 Neutral	C$59.88M	-2.97	-19.76%	―	26.91%	81.01%
STPH	49 Neutral	C$889.83K	-2.15	-13.46%	―	―	―
INNO	46 Neutral	C$29.96M	-6.72	-71.80%	―	-3.94%	-17.62%
LABS	45 Neutral	C$29.45M	-3.68	-19.10%	―	18.06%	34.58%
BNXT	42 Neutral	C$59.69M	-16.32	―	―	-62.34%	9.80%

Steep Hill Inc Corporate Events